234 related articles for article (PubMed ID: 9308642)
1. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.
Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M
Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
3. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells.
Luban NL; Williams AE; MacDonald MG; Mikesell GT; Williams KM; Sacher RA
Am J Dis Child; 1987 Apr; 141(4):416-9. PubMed ID: 3031977
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study.
Preiksaitis JK; Brown L; McKenzie M
Transfusion; 1988; 28(3):205-9. PubMed ID: 2835838
[TBL] [Abstract][Full Text] [Related]
6. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
7. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
[TBL] [Abstract][Full Text] [Related]
8. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-associated cytomegalovirus infections.
Adler SP
Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
[TBL] [Abstract][Full Text] [Related]
10. Frozen deglycerolyzed blood prevents transfusion-acquired cytomegalovirus infections in neonates.
Taylor BJ; Jacobs RF; Baker RL; Moses EB; McSwain BE; Shulman G
Pediatr Infect Dis; 1986; 5(2):188-91. PubMed ID: 3005998
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cytomegaloviral infections: recommendations for prevention and control.
Onorato IM; Morens DM; Martone WJ; Stansfield SK
Rev Infect Dis; 1985; 7(4):479-97. PubMed ID: 2994198
[TBL] [Abstract][Full Text] [Related]
12. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
Fowotade A; Okonko IO; Agbede OO; Suleiman ST
Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
[TBL] [Abstract][Full Text] [Related]
13. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
14. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters.
van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF
Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238
[TBL] [Abstract][Full Text] [Related]
15. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.
Bowden RA; Sayers M; Gleaves CA; Banaji M; Newton B; Meyers JD
Transfusion; 1987; 27(6):478-81. PubMed ID: 2825381
[TBL] [Abstract][Full Text] [Related]
17. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
Milbradt H; Flik J; Stangel W; Heigel R
Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
19. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.
Kim AR; Lee YK; Kim KA; Chu YK; Baik BY; Kim ES; Yun SC; Kim KS; Pi SY
J Korean Med Sci; 2006 Feb; 21(1):5-10. PubMed ID: 16479056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
